Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life studyPiero Barbanti, Fabrizio Vernieri, Sabina Cevoli et al.|Headache The Journal of Head and Face Pain|2020Cited by 129